CPT 87336 is referenced in 2 tracked payer policy changes from Blue Cross NC and Blue Cross & Blue Shield of Mississippi. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 87336 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.
Blue Cross NC updated multiple medical policies effective February 11, 2026, including changes to coverage criteria for STI testing, diabetes testing code additions, cervical cancer screening restrictions, and vaginitis testing limits. Several CPT codes were removed from covered services while new codes were added for specific conditions.
All tests listed in this policy are considered investigational. The policy covers miscellaneous genetic and molecular diagnostic tests not addressed in a separate review, and conclusions from a separate policy supersede this one. The code reference adds CPT 0548U (GFAP chemiluminescent immunoassay using plasma) effective 2025-04-01 and CPT 0570U (GFAP and UCH-L1 immunoassay for traumatic brain injury) effective 2025-07-01.
Watch 87336
Get one email when a payer policy names 87336, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.
See every payer rule for 87336
Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for 87336 in one place.
Get alerts for changes like this
Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.